Selected Mesenchymal Stromal Cells to Reduce Inflammation in Patients With PSC and AIH (Merlin)
An Adaptive, Multicentre, Phase IIa, Multi-disease Trial Investigating the Safety & Activity of a Single Infusion of Selected Mesenchymal Stromal Cells in the Treatment of Patients With Primary Sclerosing Cholangitis & Autoimmune Hepatitis
Sponsor: NHS Blood and Transplant
Listed as NCT02997878, this PHASE1/PHASE2 trial focuses on Cholangitis, Sclerosing and Hepatitis, Autoimmune and remains ongoing. Sponsored by NHS Blood and Transplant, it has been updated 13 times since 2018, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting PHASE1/PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE1/PHASE2
Status: Recruiting → Active Not Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Dec 2022 — Jul 2024 [monthly]
Recruiting PHASE1_PHASE2
Status: Unknown Status → Recruiting
-
Mar 2022 — Dec 2022 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
▶ Show 8 earlier versions
-
Jan 2021 — Mar 2022 [monthly]
Recruiting PHASE1_PHASE2
-
Mar 2019 — Jan 2021 [monthly]
Recruiting PHASE1_PHASE2
Status: Not Yet Recruiting → Recruiting
-
Dec 2018 — Mar 2019 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jul 2018 — Dec 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jun 2018 — Jul 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jun 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Feb 2017 — Jun 2017 [monthly]
Not Yet Recruiting PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- NHS Blood and Transplant
- University of Birmingham
For direct contact, visit the study record on ClinicalTrials.gov .